Vivos (RDGL) EBT Margin (2010 - 2025)

Vivos (RDGL) reported EBT Margin of 4357.28% for Q4 2025, up 1612696.0% on a YoY basis from N/an in Q4 2024, and up 83.86% sequentially from 26998.08% in Q3 2025.

Vivos (RDGL) EBT Margin (2010 - 2025) Analysis & Trends

Vivos (RDGL) has 15 years of EBT Margin data on file, last reported at 4357.28% in Q4 2025.

  • For the quarter ending Q4 2025, EBT Margin rose 1612696.0% year-over-year to 4357.28%; the trailing twelve-month figure through Dec 2025 stood at 4483.86% (up 591246.0% YoY), and the FY2025 full-year result was 4483.86%, up 591246.0% from the prior year.
  • EBT Margin grew to 4357.28% in Q4 2025, from 26998.08% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 1351.25% in Q3 2021 to a low of 26998.08% in Q3 2025.
  • A 5-year average of 9301.76% and a median of 6442.12% in 2022 frame the typical range for EBT Margin.
  • Peak annual rise in EBT Margin reached 1612696 bps in 2025, while the deepest fall reached 1049282 bps in 2025.
  • Tracing RDGL's EBT Margin over 5 years: stood at 1351.25% in 2021, then tumbled by 704 bps to 10857.87% in 2022, then gained by 12 bps to 9538.43% in 2023, then tumbled by 115 bps to 20484.24% in 2024, then soared by 79 bps to 4357.28% in 2025.
  • Business Quant data shows RDGL's EBT Margin at 4357.28% in Q4 2025, 26998.08% in Q3 2025, and 4303.42% in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn 12.98%
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn 14.12%
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn 18.70%
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn 22.33%
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn 27.84%
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn 22.61%
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn 9.84%
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 4.87%
10 Vivos 27.16 Mn 25.60 Mn -3,105.00 -4,357.28%

Historic Data

Download Data
DateValue
Dec 31, 2025 -4,357.28%
Sep 30, 2025 -26,998.08%
Jun 30, 2025 -4,303.42%
Mar 31, 2025 -3,120.59%
Dec 31, 2024 -20,484.24%
Sep 30, 2024 -16,505.26%
Jun 30, 2024 -3,729.32%
Mar 31, 2024 -12,411.98%
Sep 30, 2023 -9,538.43%
Jun 30, 2023 -13,885.02%
Mar 31, 2023 -4,138.63%
Dec 31, 2022 -10,857.87%
Sep 30, 2022 -4,262.54%
Jun 30, 2022 -7,500.36%
Mar 31, 2022 -5,383.88%
Sep 30, 2021 -1,351.25%
Sep 30, 2020 -1,937.01%
Dec 31, 2019 -33,602.53%
Sep 30, 2019 -8,367.15%
Mar 31, 2017 -10,280.37%